The company’s portfolio includes several PEEK interbody fusion products featuring Ti-Bond, including the recently introduced Lucent XP height- and lordosis-expandable interbody device.
“Spinal Elements has had a long, successful experience with the clinical application of Ti-Bond technology in the spine,” said Jason Blain, president and CEO of Spinal Elements. “This FDA clearance represents an important scientific element of the overall Ti-Bond story — one that will expand even more as the platform continues to flourish and we provide an increasing number of technology-based solutions to improve patient outcomes.”
More articles on surface technology:
Titan Spine completes funding round: 3 things to know
Additive manufacturing company introduces new 3D-printed PEEK application — 3 things to know
FDA clears Zimmer Biomet’s patient-specific revision knee system
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
